| Product Code: ETC9964754 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Vasudha | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 United States (US) E-Pharmacy Market Overview |
3.1 United States (US) Country Macro Economic Indicators |
3.2 United States (US) E-Pharmacy Market Revenues & Volume, 2021 & 2031F |
3.3 United States (US) E-Pharmacy Market - Industry Life Cycle |
3.4 United States (US) E-Pharmacy Market - Porter's Five Forces |
3.5 United States (US) E-Pharmacy Market Revenues & Volume Share, By Drug Type, 2021 & 2031F |
3.6 United States (US) E-Pharmacy Market Revenues & Volume Share, By Therapy Area, 2021 & 2031F |
3.7 United States (US) E-Pharmacy Market Revenues & Volume Share, By Platform, 2021 & 2031F |
4 United States (US) E-Pharmacy Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing internet penetration and smartphone usage in the United States |
4.2.2 Rising demand for convenient and time-saving healthcare solutions |
4.2.3 Growing adoption of telemedicine and digital health services |
4.2.4 Expansion of health insurance coverage and reimbursement policies for e-pharmacy services |
4.3 Market Restraints |
4.3.1 Concerns regarding data privacy and security |
4.3.2 Regulatory challenges and compliance requirements in the e-pharmacy sector |
4.3.3 Lack of personal interaction and consultation compared to traditional pharmacies |
4.3.4 Resistance from brick-and-mortar pharmacies and healthcare providers to e-pharmacy models |
5 United States (US) E-Pharmacy Market Trends |
6 United States (US) E-Pharmacy Market, By Types |
6.1 United States (US) E-Pharmacy Market, By Drug Type |
6.1.1 Overview and Analysis |
6.1.2 United States (US) E-Pharmacy Market Revenues & Volume, By Drug Type, 2021- 2031F |
6.1.3 United States (US) E-Pharmacy Market Revenues & Volume, By Over the Counter (OTC) Drugs, 2021- 2031F |
6.1.4 United States (US) E-Pharmacy Market Revenues & Volume, By Prescription Drugs, 2021- 2031F |
6.2 United States (US) E-Pharmacy Market, By Therapy Area |
6.2.1 Overview and Analysis |
6.2.2 United States (US) E-Pharmacy Market Revenues & Volume, By Diabetes, 2021- 2031F |
6.2.3 United States (US) E-Pharmacy Market Revenues & Volume, By Dermatology, 2021- 2031F |
6.2.4 United States (US) E-Pharmacy Market Revenues & Volume, By Cardiovascular, 2021- 2031F |
6.2.5 United States (US) E-Pharmacy Market Revenues & Volume, By Respiratory, 2021- 2031F |
6.2.6 United States (US) E-Pharmacy Market Revenues & Volume, By Oncology, 2021- 2031F |
6.2.7 United States (US) E-Pharmacy Market Revenues & Volume, By Immunology, 2021- 2031F |
6.3 United States (US) E-Pharmacy Market, By Platform |
6.3.1 Overview and Analysis |
6.3.2 United States (US) E-Pharmacy Market Revenues & Volume, By Web-Based, 2021- 2031F |
6.3.3 United States (US) E-Pharmacy Market Revenues & Volume, By App-Based, 2021- 2031F |
7 United States (US) E-Pharmacy Market Import-Export Trade Statistics |
7.1 United States (US) E-Pharmacy Market Export to Major Countries |
7.2 United States (US) E-Pharmacy Market Imports from Major Countries |
8 United States (US) E-Pharmacy Market Key Performance Indicators |
8.1 Percentage increase in the number of active users on e-pharmacy platforms |
8.2 Average order value (AOV) and frequency of purchases per customer |
8.3 Customer satisfaction score (CSAT) based on feedback and reviews |
8.4 Percentage of repeat purchases and customer retention rate |
8.5 Number of partnerships with healthcare providers and insurance companies for collaborations |
9 United States (US) E-Pharmacy Market - Opportunity Assessment |
9.1 United States (US) E-Pharmacy Market Opportunity Assessment, By Drug Type, 2021 & 2031F |
9.2 United States (US) E-Pharmacy Market Opportunity Assessment, By Therapy Area, 2021 & 2031F |
9.3 United States (US) E-Pharmacy Market Opportunity Assessment, By Platform, 2021 & 2031F |
10 United States (US) E-Pharmacy Market - Competitive Landscape |
10.1 United States (US) E-Pharmacy Market Revenue Share, By Companies, 2024 |
10.2 United States (US) E-Pharmacy Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here